Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + temozolomide in metastatic malignant melanoma with brain metastases
2004-005164-25Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Apr 2005
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide and thalidomide in melanoma, sponsored by University Hospital Odense. Primary endpoint: Tumor response rate. Started Apr 2005; status: completed.
02
Drugs
temozolomidethalidomide
03
Conditions
melanoma
Beyond the preview
Go deeper on 2004-005164-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005164-25.